Large-Scale Evaluation of Spatial Metabolomics Protocols and Technologies

Veronika Saharuka , Lucas M Vieira , Lachlan Stuart , Måns Ekelöf
bioRxiv 2024.01. 29.577354 -2024.01. 29.577354

2024
G007-LK

Andrey Voronkov , Daniel D Holsworth , Jo Waaler , Steven Ray Wilson

Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids

Martina Blank , Carsten Hopf
Journal of Neurochemistry 159 ( 2) 330 -342

16
2021
11
2022
Bacterial immunogenic α-galactosylceramide identified in the murine large intestine

Johanna von Gerichten , Christian Marsching , Robert Engel , Silke Herzer

2019
Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction1 [S]

Christian Marsching , Mariona Rabionet , Daniel Mathow , Richard Jennemann
Journal of lipid research 55 ( 11) 2354 -2369

26
2014
2023
1
2023
Alzheimer’s disease linked amyloid beta 1‐42 exerts product feedback inhibition on gamma‐secretase impairing downstream signaling cascades

Katarzyna Marta Zoltowska , Utpal Das , Sam Lismont , Thomas Enzlein
Alzheimer's & Dementia 19 e074247 -e074247

2023
Treatment Of Neurodegenerative Diseases By The Use Of Atp7a

Carsten Hopf , Gerard Drewes , Heinz Ruffner

4
2007
Methods for the identification of LRRK2 interacting molecules

Gerard Drewes , Carsten Hopf , Valerie Reader

3
2012
Treatment of neurodegenerative diseases by the use of scd4 inhibitors

Carsten Hopf , Gerard Drewes , Heinz Ruffner

3
2009
In vivo method for the evaluation of a compound-target interaction

Gerard Drewes , Carsten Hopf , Gitte Neubauer , Ulrich Kruse

2013
Treatment of Neurodegenerative Diseases by the Use of Gpr49

Carsten Hopf , Gerard Drewes , Heinz Ruffner

2008
Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors

Carsten Hopf , Gerard Drewes , Heinz Ruffner

2007
2005
Treatment of neurodegenerative diseases by the use of gpr49

Carsten Hopf , Gerard Drewes , Heinz Ruffner

2005